Literature DB >> 34230974

Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.

Delphine Raucher-Chéné1,2,3, Michael Bodnar4, Katie M Lavigne1,5, Ashok Malla1,6,7, Ridha Joober1,6,7, Martin Lepage1,6,7.   

Abstract

Persistent negative symptoms (PNS) are an important factor of first episode of psychosis (FEP) that present early on in the course of illness and have a major impact on long-term functional outcome. Lack of clinical insight is consistently associated with negative symptoms during the course of schizophrenia, yet only a few studies have explored its evolution in FEP. We sought to explore clinical insight change over a 24-month time period in relation to PNS in a large sample of FEP patients. Clinical insight was assessed in 515 FEP patients using the Scale to assess Unawareness of Mental Disorder. Data on awareness of illness, belief in response to medication, and belief in need for medication were analyzed. Patients were divided into 3 groups based on the presence of negative symptoms: idiopathic (PNS; n = 135), secondary (sPNS; n = 98), or absence (non-PNS; n = 282). Secondary PNS were those with PNS but also had clinically relevant levels of positive, depressive, or extrapyramidal symptoms. Our results revealed that insight improved during the first 2 months for all groups. Patients with PNS and sPNS displayed poorer insight across the 24-month period compared to the non-PNS group, but these 2 groups did not significantly differ. This large longitudinal study supported the strong relationship known to exist between poor insight and negative symptoms early in the course of the disorder and probes into potential factors that transcend the distinction between idiopathic and secondary negative symptoms.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  awareness of mental illness; clinical insight; first-episode psychosis; idiopathic negative symptoms; secondary negative symptoms

Mesh:

Year:  2022        PMID: 34230974      PMCID: PMC8781342          DOI: 10.1093/schbul/sbab079

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   7.348


  64 in total

1.  Cortical thickness is associated with poor insight in first-episode psychosis.

Authors:  Lisa Buchy; Yasser Ad-Dab'bagh; Ashok Malla; Claude Lepage; Michael Bodnar; Ridha Joober; Karine Sergerie; Alan Evans; Martin Lepage
Journal:  J Psychiatr Res       Date:  2010-11-19       Impact factor: 4.791

Review 2.  Changes in insight during treatment for psychotic disorders: a meta-analysis.

Authors:  Gerdina H M Pijnenborg; Rozanne J M van Donkersgoed; Anthony S David; André Aleman
Journal:  Schizophr Res       Date:  2013-01-08       Impact factor: 4.939

3.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

4.  Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit features.

Authors:  Hanan D Trotman; Brian Kirkpatrick; Michael T Compton
Journal:  Schizophr Res       Date:  2011-03       Impact factor: 4.939

5.  Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.

Authors:  W C Chang; Christy L M Hui; Jennifer Y M Tang; Gloria H Y Wong; May M L Lam; Sherry K W Chan; Eric Y H Chen
Journal:  Schizophr Res       Date:  2011-10-02       Impact factor: 4.939

6.  The role of illness engulfment in the association between insight and depressive symptomatology in schizophrenia.

Authors:  Susanna Konsztowicz; Martin Lepage
Journal:  J Psychiatr Res       Date:  2019-01-11       Impact factor: 4.791

7.  Self-concept and Engagement in LiFe (SELF): A waitlist-controlled pilot study of a novel psychological intervention to target illness engulfment in enduring schizophrenia and related psychoses.

Authors:  Susanna Konsztowicz; Casandra Roy Gelencser; Catherine Otis; Norbert Schmitz; Martin Lepage
Journal:  Schizophr Res       Date:  2020-12-04       Impact factor: 4.939

8.  Assessment of insight in psychosis.

Authors:  X F Amador; D H Strauss; S A Yale; M M Flaum; J Endicott; J M Gorman
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

Review 9.  Service Engagement in First-Episode Psychosis: Current Issues and Future Directions.

Authors:  Shalini Lal; Ashok Malla
Journal:  Can J Psychiatry       Date:  2015-08       Impact factor: 4.356

10.  Assessing depression in schizophrenia: the Calgary Depression Scale.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Br J Psychiatry Suppl       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.